Call for Abstract
Note
12th Asian Conference on Tumor Ablation (ACTA 2026)/ Japan Association of Systemic Therapy of Hepatocellular Carcinoma 2026 (JAST-HCC International Symposium 2026）invites the submission of abstracts for oral and poster presentations.
All abstracts must be submitted in English via the online submission system.
Abstract Submission Period
June 8 (Mon), 2026 – July 15 (Wed), 2026 at 12:00 PM(JST)
Presentation Style/Categories
Presentation style
1)Symposium(ACTA)
2)Free Papre-Oral(ACTA)
3)Free Paper-Poster(ACTA)
4)Free Papre-Oral(JAST-HCC)
5)Free Paper-Poster(JAST-HCC)
The presentation style will be decided by the Congress President based on the review results.
Session category (Symposium(ACTA))
Special Topics
| 1 | Systemic chemotherapy combined width locoregional therapy |
|---|---|
| 2 | Education in Tumor Ablation |
| 3 | Applications of AI in Tumor Ablation |
| 4 | New Technologies & Devices |
| 5 | Updates of Tumor Ablation in Asia & Oceania |
Liver
| 1 | Advanced Imaging Application in HCC Ablation |
|---|---|
| 2 | Technical Tips for HCC ablation |
| 3 | Ablation for Metastatic Liver Tumors |
| 4 | Effective Strategies for Challenging Cases in Liver |
Organs Except for Liver
| 1 | Ablation for Lung Cancer |
|---|---|
| 2 | Ablation for Breast Cancer |
| 3 | Ablation for Thyroid Nodules and Cancer |
| 4 | Ablation for Bone Tumors |
| 5 | Ablation for RCC/Adrenal Masses /Prostate Cancer |
| 6 | Ablation for Other Organs |
Specific Topics
| 1 | Robotic-assisted Tumor Ablation |
|---|---|
| 2 | HIFU & Histotripsy |
| 3 | EUS guided/Transluminal Ablation |
| 4 | IRE |
| 5 | Other |
Session category（Free Paper(ACTA)）
| 1 | Liver Cancer |
|---|---|
| 2 | Lung Cancer |
| 3 | Breast Cancer |
| 4 | Thyroid Nodules and Cancer |
| 5 | Bone Tumors |
| 6 | RCC/Adrenal Masses /Prostate Cancer |
| 7 | Other Organs |
Abstract Acceptance or Rejection
Please note that the acceptance or rejection of abstracts, as well as the presentation style, is at the sole discretion of the Congress President.
Abstract Format
| Title | Within 30 words |
|---|---|
| Length | Within 300 words (including spaces) |
Please note that the abstract will be published as submitted. We kindly ask you to carefully check for any typographical or grammatical errors before submission.
Ethical and Scientific Considerations
All studies involving human subjects or animals must have received appropriate ethical approval at the respective institution.
Case reports should ensure patient anonymity.
The presenting author must disclose any Conflict of Interest (COI) relevant to the submitted work at the time of conference presentation.
Abstract Submission
You may revise or delete your submitted abstract as many times as necessary before the submission deadline.
Please note that no changes can be made after the deadline.
To change or update your registration information, please click the “Confirmation / Modification” button.
This system is confirmed to work with Google Chrome, Microsoft Edge, and Safari.
Please do not use any other browser.
Safari is supported on version 2.0.3 (417.9.2) or later. Older versions are not compatible.
Inquiries
Congress Secretariat
12th Asian Conference on Tumor Ablation (ACTA 2026)
Japan Association of Systemic Therapy of Hepatocellular Carcinoma 2026
(JAST-HCC International Symposium 2026）
Email: actajasthcc2026@convention.co.jp
Abstract Format
Language for abstract
English
Language for presentation
English
Language for presentation slides
English
Abstract Format
| Title | Within 30 words |
|---|---|
| Length | Within 300 words (including spaces) |
Please note that the abstract will be published as submitted. We kindly ask you to carefully check for any typographical or grammatical errors before submission.
Session category (Symposium(ACTA))
Special Topics
| 1 | Systemic chemotherapy combined width locoregional therapy | 2 | Education in Tumor Ablation | 3 | Applications of AI in Tumor Ablation |
|---|---|---|---|---|---|
| 4 | New Technologies & Devices | 5 | Updates of Tumor Ablation in Asia & Oceania |
Liver
| 1 | Advanced Imaging Application in HCC Ablation | 2 | Technical Tips for HCC ablation | 3 | Ablation for Metastatic Liver Tumors |
|---|---|---|---|---|---|
| 4 | Effective Strategies for Challenging Cases in Liver |
Organs Except for Liver
| 1 | Ablation for Lung Cancer | 2 | Ablation for Breast Cancer | 3 | Ablation for Thyroid Nodules and Cancer |
|---|---|---|---|---|---|
| 4 | Ablation for Bone Tumors | 5 | Ablation for RCC/Adrenal Masses /Prostate Cancer | 6 | Ablation for Other Organs |
Specific Topics
| 1 | Robotic-assisted Tumor Ablation | 2 | HIFU & Histotripsy | 3 | EUS guided/Transluminal Ablation |
|---|---|---|---|---|---|
| 4 | IRE | 5 | Other |
Session category（Free Paper(ACTA)）
| 1 | Liver Cancer | 2 | Lung Cancer | 3 | Breast Cancer |
|---|---|---|---|---|---|
| 4 | Thyroid Nodules and Cancer | 5 | Bone Tumors | 6 | RCC/Adrenal Masses /Prostate Cancer |
| 7 | Other Organs |
Review Process
All abstracts will be peer-reviewed by members of the Scientific Committee under a double-blind review system.
Evaluation criteria include Scientific quality, Originality, Clarity of presentation, Relevance to neuro-oncology.
Notification and Publication
Notification of acceptance, presentation format, and schedule will be sent to the corresponding author by e-mail in August 2026.
Accepted abstracts will be published in the ACTA 2026 Program Booklet.
No corrections or revisions will be accepted after the submission deadline.